Group 1 - The core viewpoint of the article highlights the positive market response of baby and child concept stocks following the announcement of a new childcare subsidy policy by the Chinese government [1] - H&H International Holdings (01112) rose by 4.28% to HKD 11.7, Jinxin Fertility (01951) increased by 3.73% to HKD 3.34, Beikang Medical-B (02170) gained 2.41% to HKD 2.98, and China Feihe (06186) saw a rise of 1.7% to HKD 4.79 [1] - The new childcare subsidy policy will provide an annual subsidy of CNY 3,600 for each child until the age of three, starting from January 1, 2025, benefiting all families regardless of the number of children [1] Group 2 - According to CITIC Securities, four sectors are expected to benefit significantly from the new policy: dairy products, maternal and infant chain retail, baby products, and postpartum care services [1] - The market size for infant formula milk is projected to grow from CNY 200 billion to CNY 300 billion by 2025, indicating a strong demand for essential products [1] - Maternal and infant chain retail is expected to maintain a growth rate of over 20%, while the baby products market will continue to expand due to consumption upgrades [1] - Postpartum care services are anticipated to be the fastest-growing segment, with an annual growth rate potentially exceeding 30% [1]

Group 1 - The core viewpoint of the news highlights the strong performance of the Hong Kong innovative drug sector, with the Hong Kong Stock Connect Innovative Drug ETF (520880) reaching a historical high, increasing by 4.18% [1] - The Hong Kong Stock Connect Innovative Drug ETF tracks the Hang Seng Hong Kong Stock Connect Innovative Drug Select Index, which has seen a year-to-date increase of 107.56%, outperforming other innovative drug indices [2][3] - Major stocks in the innovative drug sector, such as Innovent Biologics, CSPC Pharmaceutical Group, and WuXi AppTec, have shown significant gains, with Innovent Biologics rising over 3% and others increasing by more than 1% [1][2] Group 2 - Analysts indicate that the innovative drug sector remains a clear trend within the pharmaceutical industry, with substantial growth potential and attractive valuations, suggesting increased foreign investment in Hong Kong innovative drugs [4] - The performance of the Hang Seng Hong Kong Stock Connect Innovative Drug Select Index has varied over the years, with historical declines in 2021, 2022, 2023, and 2024, but the current year shows a strong recovery [3]

Market Performance - The Hang Seng Index closed at 25,524 points, down 38 points or 0.2%, after a 1.2% intraday decline, indicating resilience despite early pressure[1] - The Hang Seng Tech Index fell by 0.4%, closing at 5,644 points, reflecting a similar trend[1] - Total market turnover reached HKD 267 billion, with a net inflow of HKD 12.72 billion through the Stock Connect, showing strong support[1] Market Trends - Since mid-July, cumulative net inflow through Stock Connect has reached HKD 116 billion over the past 20 trading days, indicating increased investor interest[1] - The market is experiencing a high risk appetite, particularly in the biotech and brokerage sectors, with several biotech stocks hitting new highs[1] Short-term Risks - The Hang Seng Index faces short-term adjustment risks due to three factors: 1. Technical indicators are overbought, with the 50-day and 250-day moving averages at extreme levels of 93%[2] 2. August has historically been a weak month for the index, with an average decline of 2.1% over the past 15 years and a rise rate of only 26.7%[2] 3. The US dollar may rebound, as it has historically increased by an average of 0.1% in August, potentially pressuring emerging markets like Hong Kong[2] Policy Impact - Government policies, such as the implementation of a nationwide childcare subsidy starting January 1, 2025, are expected to boost market sentiment[3] - The healthcare sector saw a significant rise, with the Hang Seng Healthcare Index up 3.8%, driven by strong performances in innovative drugs and medical devices[4] Real Estate Insights - New home sales in 30 major cities fell by 16.8% year-on-year, with a total volume of 1.4 million square meters sold, indicating ongoing weakness in the real estate market[5] - The inventory-to-sales ratio for major cities rose to 129.8, up from 101.3 a year ago, suggesting increasing supply pressure[7] - Land transaction volumes also dropped significantly, down 48.6% year-on-year, reflecting a slowdown in real estate development activity[8]

迎政策红利婴童股集体涨停，乳业涨幅居前 千亿育儿补贴政策落地在即，"每孩每年3600元补贴""新生儿自带奶粉钱"等话题占据焦点。资本市场婴 童概念股最先被"点燃"，细分领域方面，包括乳业、母婴连锁、婴幼儿用品、产后护理等均迎来大涨。 昨日，婴童相关概念股开盘飘红，乳业板块涨幅居前，贝因美、爱婴室、诺邦股份（603238）涨停，骑 士乳业一度涨超26%，西部牧业（300106）涨超13%，太湖雪、孩子王涨超10%，阳光乳业、延江股份 （300658）、可靠股份（301009）、戴维医疗（300314）等涨超5%，熊猫乳品（300898）、嘉必优、 均瑶健康（605388）、三元股份（600429）、皇氏集团（002329）、光明乳业（600597）等跟涨；港股 锦欣生殖涨8.93%，H&H国际控股涨7.33%，贝康医疗-B涨5.19%，中国飞鹤涨5.12%，圣贝拉涨 3.13%。 不过，截至下午收盘，相关概念股涨幅均有所收窄。A股方面，阳光乳业涨停，骑士乳业涨幅超5%， 贝因美、爱婴室、孩子王、皇氏集团、均瑶健康等涨幅居前；港股方面，中国飞鹤微涨，涨幅为 0.43%，多只概念股翻绿。 消息面上，7月28日，国家 ...

国家育儿补贴政策出台，母婴概念股迎来爆发式增长。 政策利好下，市场机构纷纷上调对母婴行业的发展预期。 7月28日，中共中央办公厅、国务院办公厅近日印发的《育儿补贴制度实施方案》明确，从2025年1月1 日起，对符合法律法规规定生育的3周岁以下婴幼儿发放补贴，至其年满3周岁。育儿补贴按年发放，现 阶段国家基础标准为每孩每年3600元。这一重大利好消息立即在资本市场引发强烈反响。 7月29日,港股、A股开盘后，母婴概念股集体爆发，形成了一道亮丽的"红色风景线"。其中，A股贝因 美（002570.SZ）、爱婴室（603214.SH）等个股强势涨停，孩子王（301078.SZ）、骑士乳业 (832786.BJ)等涨幅超过10%。港股婴童概念股亦多数高开，锦欣生殖 (01951) 涨 8.93%；H&H 国际控股 (01112) 涨 7.33%；中国飞鹤 (06186) 涨 5.12%；圣贝拉 (02508) 涨 3.13%，报 7.9 港元。简言之，母婴板 块成为当日市场最耀眼的明星板块。 | 一元县大 | 34.93 +21.07% +38.94% | | --- | --- | | 837344 | | | 领涨 ...

今日上榜个股中，小米集团-W、腾讯控股、阿里巴巴-W等8只股同时上榜港股通（深）、港股通（沪）成交活跃股， 小米集团-W合计成交额 83.68亿港元，成交净买入16.59亿港元，腾讯控股合计成交额45.43亿港元，成交净买入8.33亿港元。泡泡玛特合计成交额23.37亿港元，成交净卖 出3.51亿港元，美团-W合计成交额37.51亿港元，成交净卖出2.88亿港元。 从连续性进行统计， 有4只股获南向资金连续3天以上净买入，连续净买入天数较多的有腾讯控股、中芯国际、阿里巴巴-W，连续净买入天数分 别为4天、3天、3天。以其间净买入金额统计，净买入金额最多的是小米集团-W，合计净买入为24.46亿港元，其次是腾讯控股合计净买入为20.89 亿港元，中芯国际合计净买入为13.03亿港元。（数据宝） | 7月29日南向资金成交活跃股 | | --- | | 代码 简称 | 成交金额 成交净买入 | 今日涨跌幅（%） | | --- | --- | --- | | | （万港元） （万港元） | | | 01810 小米集团-W | 836751.42 165918.68 -2.64 | | | 00700 腾讯控股 ...

Core Viewpoint - The Hang Seng Index fell by 0.15% to close at 25,524.45 points on July 29, with a net inflow of HKD 12.72 billion through the southbound trading channel [1] Group 1: Market Activity - The total trading volume for the southbound trading on July 29 was HKD 155.49 billion, with a net buy of HKD 12.72 billion [1] - The Shanghai Stock Exchange's southbound trading accounted for HKD 98.34 billion in trading volume, with a net buy of HKD 5.88 billion, while the Shenzhen Stock Exchange had a trading volume of HKD 57.15 billion and a net buy of HKD 6.84 billion [1] Group 2: Active Stocks - The most actively traded stock on the Shanghai Stock Exchange was Xiaomi Group-W, with a trading volume of HKD 5.36 billion, followed by Guotai Junan International and Tencent Holdings, with trading volumes of HKD 4.15 billion and HKD 3.00 billion, respectively [2] - In terms of net buying, Tencent Holdings led with a net buy of HKD 1.06 billion, despite its stock price closing down by 0.09% [1][2] - The stock with the highest net sell was Pop Mart, with a net sell of HKD 272 million, while its stock price increased by 5.91% [1][2] Group 3: Detailed Stock Data - The top ten actively traded stocks on the Shenzhen Stock Exchange included Xiaomi Group-W with a trading volume of HKD 3.00 billion and a net buy of HKD 670 million, despite a closing drop of 2.64% [2] - Meituan-W had the highest net sell amount of HKD 509 million, with a closing price decrease of 0.62% [2] - Other notable stocks included Alibaba-W and Southbound Hang Seng Technology, with trading volumes of HKD 2.24 billion and HKD 1.67 billion, respectively [2]

7月29日港股市场，北水成交净买入127.2亿港元，其中港股通(沪)成交净买入58.78亿港元，港股通(深) 成交净买入68.42亿港元。 中芯国际 锦欣生殖 石药集团 中芯国际 腾讯控股-R 腾讯控股 分时图 日K线 周K线 月K线 114.76 0.00 0.00% 1.00% 0.67% 0.33% 0.00% 0.33% 0.67% 1.00% 113.61 113.99 114.38 114.76 115.14 115.53 115.91 09:30 10:30 11:30/13:00 14:00 15:00 15:30 0 0 1 1 北水净买入最多的个股是小米集团-W(01810)、腾讯(00700)、阿里巴巴-W(09988)。北水净卖出最多的 个股是南方恒生科技(03033)。 | 股票名称 | 买入额 | 卖出额 | 买卖总额 | | --- | --- | --- | --- | | | | | 净流入 | | 小米集团-W | 31.76亿 | 21.87亿 | 53.64亿 | | HK 01810 | | | +9.89 亿 | | 国泰君安 ... | 21.58亿 | 19.9 ...

| 中芯国际 | 6.421Z | 5.18 亿 | 11.60亿 | | --- | --- | --- | --- | | HK 00981 | | | +1.24 亿 | | 快手-W | 4.62亿 | 4.71亿 | 9.33亿 | | HK 01024 | | | -850.31万 | | 石药集团 | 5.88亿 | 3.24亿 | 9.11亿 | | HK 01093 | | | +2.64 乙 | | 信达生物 | 6.77 亿 | 1.62亿 | 8.39亿 | | HK 01801 | | | +5.141Z | | 泡泡玛特 | 3.63亿 | 4.43亿 | 8.06亿 | | HK 09992 | | | -7973.47万 | 港股通(深)活跃成交股 | 股票名称 | 买入额 | 卖出额 | 买卖总额 | | --- | --- | --- | --- | | | | | 净流入 | | 小米集团-W HK 01810 | 31.76亿 | 21.87 亿 | 53.64亿 | | | | | +9.89 亿 | | 国泰君安 ... | 21.58亿 | 19.90亿 | 41 ...

| 公司名称 | 成交金额 | 净买入额 | | --- | --- | --- | | 小米集团-W(01810) | 53.64 亿元 | +9.89 亿元 | | 国泰君安国际(01788) | 41.48 亿元 | +1.69 亿元 | | 腾讯控股(00700) | 30.04 亿元 | +10.60 亿元 | | 阿里巴巴-W(09988) | 22.43 亿元 | +2.02 亿元 | | 中芯国际(00981) | 21.86 亿元 | +2.43 亿元 | | 美团-W(03690) | 20.67 亿元 | +2.21 亿元 | | 南方恒生科技(03033) | 16.71 亿元 | -6787.71 万元 | | 锦欣生殖(01951) | 15.63 亿元 | +1.95 亿元 | | 泡泡玛特(09992) | 15.31 亿元 | -2.72 亿元 | | 石药集团(01093) | 14.85 亿元 | +3.88 亿元 | 智通财经APP获悉，2025年7月29日当天，小米集团-W(01810)、国泰君安国际(01788)、腾讯控股 (00700)位居沪港通（南向）成交额前3 ...